IP Library Granted Patent US 12,305,146
Granted Patent B2
US 12,305,146 · App. 17/289,488 · Granted May 20, 2025

Composition for cleaning and assessing cleanliness in real-time

Inventors: Huyen Bui (Brooklyn Park, MN); Tuan Nguyen (Chaska, MN); Mer Win Cheong (Pomezia, IT); Kristopher Murphy (New Brighton, MN); Nicholas G. Bromiley (Annandale, MN); Joseph G. Johnnie (Pearland, TX); Jing Yu (Pasadena, CA)
Assignee: Medivators Inc.
C11D1/72C11D1/722C11D3/0026C11D3/0047C11D3/0073C11D3/044C11D3/06C11D3/2041C11D3/2072C11D3/2096C11D3/33C11D3/48C11D2111/20C11D2111/46
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,305,146
App. No.
17/289,488
Granted
May 20, 2025
Kind
B2
Abstract

This disclosure describes a composition which can provide real-time feedback during medical device cleaning or reprocessing. The composition can be used to monitor the amount of biological material cleaned from medical devices and to determine when cleaning is complete. The disclosure also relates to a method of cleaning, or assessing the cleanliness of, a medical device such as an endoscope. Cleanliness can be assessed by contacting the medical device with the composition, shining an excitation light on the composition, and measuring intensity of resulting fluorescence over time.

Claims (27)

1. A composition for detecting residual biological material, the composition comprising ortho-phthalaldehyde, a glycol, a surfactant, a buffer system, an Arrhenius base, a chelator, a corrosion inhibitor and water, wherein the composition has a pH between 11.9 and 12.2; wherein the composition is an aqueous solution.

2. The composition of claim 1 , wherein the Arrhenius base is lithium hydroxide, sodium hydroxide, potassium hydroxide, cesium hydroxide, magnesium hydroxide, or calcium hydroxide.

3. The composition of claim 1 , wherein ortho-phthalaldehyde is at least 0.35 wt % of the composition.

4. The composition of claim 3 , wherein ortho-phthalaldehyde is 0.35 wt % to about 1.00 wt % of the composition.

5. The composition of claim 1 , wherein the surfactant comprises one or more non-ionic surfactant.

6. The composition of claim 5 , wherein the surfactant comprises one or more ethoxylated alcohol.

7. The composition of claim 6 , wherein the surfactant comprises C9-C11 ethoxylated alcohols.

8. The composition of claim 7 , wherein about 0.05 wt % to about 10 wt % of the composition is C9-C11 ethoxylated alcohol.

9. The composition of claim 1 , wherein the buffer system is a mixture of potassium phosphate dibasic and sodium hydroxide.

10. The composition of claim 1 , further comprising a glycol ether.

11. The composition of claim 10 , wherein the glycol ether is about 0.05 wt % to about 10 wt % of the composition.

12. The composition of claim 10 , wherein the glycol ether is diethylene glycol monoethyl ether.

13. The composition of claim 1 , wherein the chelator is ethylenediaminetetraacetic acid.

14. The composition of claim 1 , wherein the corrosion inhibitor is benzotriazole or sodium dodecyl sulfate.

15. The composition of claim 1 , further comprising an antifoaming agent.

16. The composition of claim 15 , wherein the antifoaming agent is a polyoxypropylene-polyoxyethylene block copolymer.

17. A composition comprising:

ortho-phthalaldehyde which is 0.35 wt % to about 1.00 wt % of the composition,

propylene glycol which is about 0.10 wt % to about 20.0 wt % of the composition, C9-C11 ethoxylated alcohols which are about 0.05 wt % to about 10 wt % of the composition,

ethylenediaminetetraacetic acid which is about 0.01 wt % to about 2 wt % of the composition,

phosphate buffer,

sodium hydroxide,

an Arrhenius base and

water; wherein the composition is in liquid form and has a pH between 11.9 and 12.2, wherein the composition is an aqueous solution.

18. The composition of claim 1 , wherein the solution contains no straight chain alcohols.

19. The composition of claim 17 , wherein the composition is suitable for assessing cleanliness.

20. The composition of claim 17 , wherein the composition is suitable for the detection of residual biological material.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2021
From: BUI, HUYEN; NGUYEN, TUAN; CHEONG, MER WIN; MURPHY, KRISTOPHER; BROMILEY, NICHOLAS G.; JOHNNIE, JOSEPH G.; YU, JING
To: MEDIVATORS INC.
Reel/Frame 056085/0721 →
Continuity (2)
Provisional Application 62755789 · Nov 5, 2018
Related Publication 20220195334A1 · Jun 23, 2022
References Cited (78)
US 6013034A · Fernandes Da Cunha Vaz et al. · 2000 [cited by applicant]
US 6174291B1 · McMahon et al. · 2001 [cited by applicant]
US 6694176B1 · Tsujita et al. · 2004 [cited by applicant]
US 6793880B2 · Kippenhan, Jr. · 2004 [cited by applicant]
US 7905831B2 · Noguchi et al. · 2011 [cited by applicant]
US 7918788B2 · Lin et al. · 2011 [cited by applicant]
US 7942810B2 · Uchimura et al. · 2011 [cited by applicant]
US 8084756B2 · Tokhtuev et al. · 2011 [cited by applicant]
US 8227766B2 · Chapman · 2012 [cited by applicant]
US 8353818B1 · Sasaki · 2013 [cited by applicant]
US 8454937B2 · Claudio · 2013 [cited by applicant]
US 8593626B2 · Brouwer · 2013 [cited by applicant]
US 8933008B2 · Whiteley · 2015 [cited by examiner]
US 9167160B2 · King · 2015 [cited by applicant]
US 9566415B2 · Soutorine · 2017 [cited by applicant]
US 9649019B2 · Noack · 2017 [cited by applicant]
US 9820630B2 · Tomita · 2017 [cited by applicant]
US 9892513B2 · Gurevich et al. · 2018 [cited by applicant]
US 9907624B2 · Vazales et al. · 2018 [cited by applicant]
US 10254224B2 · Bolduc et al. · 2019 [cited by applicant]
US 10266793B2 · Labib et al. · 2019 [cited by applicant]
US 10358622B2 · Stokes et al. · 2019 [cited by applicant]
US 10660505B2 · Irion et al. · 2020 [cited by applicant]
US 10702353B2 · Tesar · 2020 [cited by applicant]
US 10702619B2 · Fang et al. · 2020 [cited by applicant]
US 10705020B2 · Baribeau · 2020 [cited by applicant]
US 10709313B2 · Stephenson · 2020 [cited by applicant]
US 20070161859A1 · Kubach · 2007 [cited by applicant]
US 20100068237A1 · Li et al. · 2010 [cited by applicant]
US 20110104223A1 · Li · 2011 [cited by applicant]
US 20120041305A1 · Grissom et al. · 2012 [cited by applicant]
US 20120073614A1 · Otani et al. · 2012 [cited by applicant]
US 20130203845A1 · Whiteley et al. · 2013 [cited by applicant]
US 20140011726A1 · Mitchell · 2014 [cited by examiner]
US 20150238085A1 · Inoue et al. · 2015 [cited by applicant]
US 20160025653A1 · Jalilian et al. · 2016 [cited by applicant]
US 20160081531A1 · Yoshie · 2016 [cited by applicant]
US 20160279658A1 · Li et al. · 2016 [cited by applicant]
US 20170027420A1 · Choi et al. · 2017 [cited by applicant]
US 20170332891A1 · Yang et al. · 2017 [cited by applicant]
US 20170333584A1 · Fang et al. · 2017 [cited by applicant]
US 20180007895A1 · Karandikar · 2018 [cited by examiner]
US 20180094214A1 · Labib · 2018 [cited by examiner]
CN 1613308 · 2005 [cited by applicant]
CN 1836508 · 2006 [cited by applicant]
CN 1964665 · 2007 [cited by applicant]
CN 101564545 · 2009 [cited by applicant]
CN 102580124B · 2013 [cited by applicant]
CN 103749445 · 2014 [cited by applicant]
CN 105346758 · 2016 [cited by applicant]
CN 105379712 · 2016 [cited by applicant]
CN 107711835A · 2018 [cited by applicant]
CN 108552173A · 2018 [cited by applicant]
CN 108627519 · 2018 [cited by applicant]
EP 1468700A1 · 2004 [cited by examiner]
EP 2144635A · 2017 [cited by applicant]
JP 2971608 · 1999 [cited by applicant]
JP 2005305182 · 2005 [cited by applicant]
JP 2008007408A2 · 2008 [cited by applicant]
JP 2008054861 · 2008 [cited by applicant]
JP 2009142490 · 2009 [cited by applicant]
JP 2009165506 · 2009 [cited by applicant]
JP 2009172054 · 2009 [cited by applicant]
JP 2014041043 · 2014 [cited by applicant]
KR 20130079386 · 2013 [cited by applicant]
KR 20150123421A · 2015 [cited by applicant]
WO 2006096797 · 2006 [cited by applicant]
WO 2009032644A2 · 2009 [cited by applicant]
WO 2010129532 · 2010 [cited by applicant]
WO WO2016197148A1 · 2016 [cited by examiner]
WO WO2017027418A1 · 2017 [cited by examiner]
WO WO2017148524A1 · 2017 [cited by examiner]
International Search Report and Written Opinion of the International Searching Authority Dated Feb. 14, 2020, of International PCT Application No. PCT/US2019/59357 filed Nov. 1, 2019. [cited by applicant]
Peer Contribution by China National Intellectual Property Jan. 16, 2020, of International PCT Application No. PCT/US2019/59357 filed Nov. 1, 2019. [cited by applicant]
Peer Contribution by European Patent Office Jan. 15, 2020, of International PCT Application No. PCT/US2019/59357 filed Nov. 1, 2019. [cited by applicant]
Peer Contribution by Japan Patent Office Jan. 21, 2020, of International PCT Application No. PCT/US2019/59357 filed Nov. 1, 2019. [cited by applicant]
Peer Contribution by Korean Intellectual Property Office Jan. 20, 2020, of International PCT Application No. PCT/US2019/59357 filed Nov. 1, 2019. [cited by applicant]
International Preliminary Report on Patentability issued in PCT/US2019/059357, mailed May 20, 2021. [cited by applicant]